However in a multivariate analysis in which all events were evaluated in relation to relevant prognostic factors, such as pathological stage, tumor grade, estrogen receptor expression, nodal status, Ki67 and Her2/Neu expression, JAM-A lost its predictive power (Table 2). This evidence concerns the gene ESR1 and neoplasm.